NK

Naresh Kumar Goyal

Director Director DIN 06526386
DIN 06526386 First appointment Jun 2013 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Naresh Kumar Goyal

Data last updated:

Naresh Kumar Goyal was a Director at Nuvo Medsurg Private Limited (2013–2025) and Director at Rnps Pharma Private Limited (from 2015). The companies operate in Healthcare.

DIN 06526386
Primary Designation Director
Industry Healthcare
First Appointment 14 Jun 2013
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nuvo Medsurg Private Limited U51900DL2013PTC253968
Director14 Jun 20132013₹10.67 Cr (FY 2024)Active
Rnps Pharma Private Limited U24100DL2015PTC286567
Director19 Oct 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rnps Pharma Private Limited
Nuvo Medsurg Private Limited
Premium access

Shareholding and investment profile for Naresh Kumar Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kumar Goyal

Naresh Kumar Goyal was first appointed on 14 Jun 2013 as Director at Nuvo Medsurg Private Limited. The most recent appointment on record is 19 Oct 2015 at Rnps Pharma Private Limited.

Naresh Kumar Goyal held 2 earlier board appointments: Nuvo Medsurg Private Limited (Director, 14 Jun 2013 to 18 Mar 2025); Rnps Pharma Private Limited (Director, from 19 Oct 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available